MDH.LSE Mendell Helium plc

Healthcare Drug Manufacturers - Specialty & Generic London Exchange
0.0322 GBX
Close of Nov 3, 2026
2.87 6.00
Market cap
GBX 11.5M
P/E
-
P/B
6.57x
ROE
-69.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Mar 2026.

Is MDH.LSE undervalued?

Graham number

The Graham number of Mendell Helium plc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Mendell Helium plc fundamental analysis

No fundamental analysis for Mendell Helium plc yet.

Mendell Helium plc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Mendell Helium plc

Mendell Helium plc engages in the production of helium in the United States. It holds an interest in the Fort Dodge prospect and well located in Ford County and various wells in its Hugoton North Play project located in Garden City in southwestern Kansas. In addition, it produces natural gas. The company was formerly known as Voyager Life plc and changed its name to Mendell Helium plc in September 2024. Mendell Helium plc was incorporated in 2020 and is headquartered in Pert…

Full company profile